Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Boston Scientific Announces Strategic Investment To Acquire Majority Stake Of Acotec Scientific Holdings Limited

PUBLIC · BSXSep 01, 20267 days ago

Acquiring Company

Boston Scientific

Acquired Company

Acotec Scientific Holdings Limited

MarlboroughBeijingManufacturingBiotechnologyHealth CareMedicalMedical DeviceBiotechnologyHealth CareMedicalMedical Device

Description

Boston Scientific Corporation (NYSE: BSX) and Acotec Scientific Holdings Limited ("Acotec" and 6669.HK) announced today that Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, a Chinese medical technology company that offers solutions designed for a variety of interventional procedures. The proposed price is HK$20 per share, which represents a total upfront cash payment consideration of approximately US$523 million for the 65% stake at current exchange rates.

Company Information

Company

Boston Scientific

Location

Marlborough, Massachusetts, United States

About

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

Don't miss Boston Scientific's next move

Get an email the moment Boston Scientific makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Madan
Likely contact at this company
••••••••@••••••••

See Madan's verified email →

Marine
Senior decision-maker at this company
••••••••@••••••••

See Marine's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Boston Scientific's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Acotec Scientific Holdings Limited?

Acotec Scientific Holdings Limited was acquired by Boston Scientific, based in Marlborough. The deal was reported on September 1, 2026. Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. Boston Scientific is publicly traded (BSX) and operates in Manufacturing.

When did Boston Scientific acquire Acotec Scientific Holdings Limited?

Boston Scientific's acquisition of Acotec Scientific Holdings Limited was reported on September 1, 2026. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Acotec Scientific Holdings Limited do?

Acotec Scientific Holdings Limited is a medical technology company listed in Hong Kong that develops and commercialises interventional medical devices. It is privately held, operating in Biotechnology, and is based in Beijing.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.